VAMC, Long Beach
Long Beach, California, United States
NCT Number: NCT00011557
This project will determine the ultimate usefulness of functional magnetic stimulation (FMS) as an assistive device for voiding in patients with SCI.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2
Long Beach, California, United States
Investigators intend to determine the ultimate usefulness of functional magnetic stimulation (FMS) as an assistive device for voiding in patients with SCI.
Thirty six persons will be recruited and will undergo an 8 week protocol for conditioning of the bladder. The investigators propose to: investigate the changes in bladder function in response to long-term bladder conditioning by FMS; further optimize the FMS technology and parameters for effective bladder emptying in SCI; evaluate the role of the external sphincter muscle fatigue by FS in facilitating bladder emptying; critically evaluate the relative response of FMS data to existing information using functional electrical stimulation;further develop criteria that will be used to predict which SCI patients are optimally suitable for FMS; establish a comprehensive stimulation criteria that will reflect the safety and effectiveness of structures associated with the bladder that are exposed to the electro-myographic field.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Patients with SCI above T10 level, six months post injury
Looking for future studies?
Notify MeUS Department of Veterans Affairs
Fed
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07842003
Central Nervous System Diseases, Nervous System Diseases
Ahmedabad, Gujarat, India
View Trial DetailsNCT07810712
Brain Diseases, Cardiovascular Diseases
Liverpool, United Kingdom
View Trial DetailsNCT07550699
Acquired Brain Injury (Including Stroke), Autoimmune Diseases
Vienna, State of Vienna, Austria
View Trial DetailsNCT06815601
Central Nervous System Diseases, Nervous System Diseases
Buffalo, New York, United States
View Trial Details